Peer-reviewedCC BYFrontiers in immunology
Diet, hormones, and breast cancer: biomarker-guided assessment of risk and prognosis
- 1Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , ,
Related
- CMVAE: Contrastive Supervision Improves Single-Omic Latent Manifold for Breast Cancer Survival Prognosis
- A Network-Based Biomarker of Morphological Disruption Associated with Breast Cancer Malignancy
- cGAS–STING signalling in triple-negative breast cancer: a functional-state framework for biomarker-guided intervention
- Family history and stage at diagnosis but not prognosis in female breast cancer: a large registry-based cohort study from Iran.
- Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer.
BibTeX
@article{liu2026diet,
title = {{Diet, hormones, and breast cancer: biomarker-guided assessment of risk and prognosis}},
author = {Jia Liu and Mohan Liu and Xiaoying Zhong and Qiang Sun and Xingtong Zhou},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659577},
note = {CC BY},
}
RIS
TY - JOUR
TI - Diet, hormones, and breast cancer: biomarker-guided assessment of risk and prognosis
AU - Jia Liu
AU - Mohan Liu
AU - Xiaoying Zhong
AU - Qiang Sun
AU - Xingtong Zhou
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13659577
SN - 1664-3224
ER -